1.49
price up icon7.97%   0.11
after-market Handel nachbörslich: 1.42 -0.07 -4.70%
loading
Schlusskurs vom Vortag:
$1.38
Offen:
$1.44
24-Stunden-Volumen:
202.74K
Relative Volume:
1.10
Marktkapitalisierung:
$97.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.6906
EPS:
-2.1574
Netto-Cashflow:
$-72.06M
1W Leistung:
-1.32%
1M Leistung:
-8.02%
6M Leistung:
+60.94%
1J Leistung:
+26.27%
1-Tages-Spanne:
Value
$1.42
$1.50
1-Wochen-Bereich:
Value
$1.30
$1.55
52-Wochen-Spanne:
Value
$0.66
$1.73

Io Biotech Inc Stock (IOBT) Company Profile

Name
Firmenname
Io Biotech Inc
Name
Telefon
(457) 070-2980
Name
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Name
Mitarbeiter
79
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
IOBT's Discussions on Twitter

Vergleichen Sie IOBT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IOBT
Io Biotech Inc
1.49 97.50M 0 -86.08M -72.06M -2.1574
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

pulisher
Jun 17, 2025

IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Down 35.0% in May - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

IO Biotech Regains Nasdaq Compliance with Stock Price - MSN

Jun 15, 2025
pulisher
Jun 14, 2025

Wall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to “Sell” - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

NSCLC Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 10+ Companies and 10+ Therapies | DelveInsight - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Jun 11, 2025
pulisher
Jun 10, 2025

Metastatic Melanoma Pipeline Appears Robust With 20+ Key Pharma - openPR.com

Jun 10, 2025
pulisher
Jun 09, 2025

IO Biotech reports annual meeting results By Investing.com - Investing.com Nigeria

Jun 09, 2025
pulisher
Jun 09, 2025

IO Biotech reports annual meeting results - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

IO Biotech Elects New Director at Annual Meeting - TipRanks

Jun 09, 2025
pulisher
Jun 07, 2025

Citadel Advisors LLC Purchases Shares of 270,504 IO Biotech, Inc. (NASDAQ:IOBT) - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

IO Biotech Regains Compliance With Nasdaq Listing Rules - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

io biotech regains nasdaq compliance after bid price recovery By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

io biotech regains nasdaq compliance after bid price recovery - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

Director Heidi Hunter Acquires 15,000 Shares of IO Biotech Inc (IOBT) - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Stocks in play: Corus Entertainment - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Io biotech director Heidi Hunter purchases $20,884 in common stock By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Io biotech director Heidi Hunter purchases $20,884 in common stock - Investing.com Australia

Jun 02, 2025
pulisher
Jun 01, 2025

5 Best Microbiome Companies (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 31, 2025

Here Are My Top 3 High-Yield Pipeline Stocks to Buy Now - The Globe and Mail

May 31, 2025
pulisher
May 30, 2025

Pembina Pipeline Corporation Announces Redemption of Series 19 Preferred Shares - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

3 Internet Software Stocks to Buy From a Prospering Industry - The Globe and Mail

May 30, 2025
pulisher
May 29, 2025

Cancer Vaccines Market Sees Boost from UK's New Injection and Korea's Cell Conversion Research - openPR.com

May 29, 2025
pulisher
May 29, 2025

Dividend 15 Split Corp. II Announces TSX Acceptance of Normal Course Issuer Bid - The Globe and Mail

May 29, 2025
pulisher
May 28, 2025

IO Biotech, Inc. (IOBT) Just Flashed Golden Cross Signal: Do You Buy? - sharewise

May 28, 2025
pulisher
May 27, 2025

Beyond Lithium Completes Acquisition of Rare One Project in Southeastern British Columbia - The Globe and Mail

May 27, 2025
pulisher
May 27, 2025

Targeting solid tumors two ways with one cancer vaccine - drugdiscoverynews.com

May 27, 2025
pulisher
May 25, 2025

Prediction: This Will Be the First Mega Technology Company to Split Its Stock in 2025 (and It Isn't Tesla) - The Globe and Mail

May 25, 2025
pulisher
May 23, 2025

Io Biotech Inc Files For Resale Of Up To 5.6 Million Shares Of Common Stock By The Selling StockholdersSEC Filing - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

IOBT Investors: Understanding Stockholder Sales Impact | IOBT St - GuruFocus

May 23, 2025
pulisher
May 22, 2025

2 "Magnificent Seven" Stocks Billionaires Are Buying - The Globe and Mail

May 22, 2025
pulisher
May 21, 2025

Elliott Waves: Dollar Index Can Be Targeting New Lows - The Globe and Mail

May 21, 2025
pulisher
May 20, 2025

IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference - The Manila Times

May 20, 2025
pulisher
May 20, 2025

Cancer Vaccine Developer IO Biotech Headlines Two Major Healthcare Conferences This Summer - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Is NIO Stock Set for a Comeback? Fundamentals Say Yes - The Globe and Mail

May 19, 2025
pulisher
May 19, 2025

Q2 Earnings Forecast for IO Biotech Issued By HC Wainwright - Defense World

May 19, 2025
pulisher
May 18, 2025

Sustainable Success Stories: 2 U.S. Companies With a Legacy of Growth - The Globe and Mail

May 18, 2025
pulisher
May 16, 2025

Why Alphabet Stock Ticked Higher Today - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

IO Biotech Advances Cancer Vaccine Trials in Q1 2025 - TipRanks

May 16, 2025
pulisher
May 15, 2025

IO Biotech price target raised to $14 from $12 at H.C. Wainwright - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Why American Eagle Stock Plummeted After Earnings - The Globe and Mail

May 14, 2025
pulisher
May 14, 2025

IO Biotech, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 14, 2025
pulisher
May 13, 2025

‘We’re Delivering Real Progress Toward Profitability:’ Is Plug Power Stock a Buy, Sell, or Hold After Earnings? - The Globe and Mail

May 13, 2025
pulisher
May 11, 2025

IO Biotech (IOBT) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

4 No-Brainer Stocks to Buy Right Now - The Globe and Mail

May 09, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Raises Stake in IO Biotech, Inc. (NASDAQ:IOBT) - Defense World

May 08, 2025
pulisher
May 08, 2025

“Horrible Things Done to Slack,” says Salesforce (NYSE:CRM) CEO Benioff about Microsoft - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of IO Biotech, Inc. (NASDAQ: IOBT) and Encourages IOBT Shareholders to Contact the Firm - ACCESS Newswire

May 07, 2025

Finanzdaten der Io Biotech Inc-Aktie (IOBT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Io Biotech Inc-Aktie (IOBT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Ahmad Qasim Iftikhar
Chief Medical Officer
Dec 23 '24
Buy
0.85
31,350
26,553
31,350
Zocca Mai-Britt
Chief Executive Officer
Dec 23 '24
Buy
0.81
12,500
10,120
49,891
Sullivan Amy
Chief Financial Officer
Dec 23 '24
Buy
0.83
10,250
8,483
84,632
Smith Devin Whittemore
General Counsel
Dec 23 '24
Buy
0.81
12,000
9,720
16,938
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):